|Last Price||Today's Change||52-Week Range||Trading Volume|
|0.87 CAD||-0.03 (-3.33%)||0.445 - 1.79||85.6 thousand (Above Avg)|
Market data as of 9:52AM 04/27/15. Quotes are delayed by at least 15 min.
Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 2015 AACR Annual Meeting
PR Newswire - Monday 04/20/2015 6:30 AM ET
Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Malignant Gliomas
PR Newswire - Friday 04/17/2015 6:30 AM ET
Oncolytics Biotech® Inc. Presents at UK Immuno-oncology Meeting
PR Newswire - Wednesday 04/15/2015 6:30 AM ET
Media Advisory - Oncolytics Biotech® Inc. to Participate in the 14th Annual Needham Healthcare Conference
PR Newswire - Monday 04/13/2015 6:30 AM ET
Oncolytics Biotech® Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Gastric Cancer
PR Newswire - Tuesday 04/07/2015 6:30 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.